Science News from #ACC22

April 2–4, 2022
Washington, D.C.

Jump to another day's coverage: Saturday | Sunday | Monday

Selected science from Saturday, April 2

Also published on Saturday

FAME 3: Quality of Life After Fractional Flow Reserve-Guided PCI Compared with Coronary Bypass Surgery
William F. Fearon | Stanford University, Stanford, CA, et al.
Published in Circulation

Selected science from Sunday, April 3

Also published Sunday

TRANSLATE-TIMI 70: Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol
Brian A. Bergmark | Brigham and Women's Hospital, Harvard Medical School, Boston, MA, et al.

Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial
Paolo Della Bella | San Raffaele University-Hospital, Milan, Italy, et al.

Selected science from Monday, April 4

Also published Monday

ADAPT-TAVR: Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial
Duk-Woo Park | University of Ulsan College of Medicine, Seoul, Korea, et al.

CHOCOLATE TOUCH: A Randomized Trial of Chocolate Touch Compared with Lutonix Drug-Coated Balloon in Femoropopliteal Lesions
Mehdi H. Shishehbor | University Hospitals Harrington Heart and Vascular Institute, Cleveland, OH, et al.